A comparison of @entity3175 and @entity4390 in premedication for upper XXXX : a randomized double blind controlled study.

@entity1 @entity3175 @entity390 @entity4390 @entity391 @entity344 @entity2730 @entity6513 @entity3897 @entity3527
A variety of agents are used as premedication for upper @entity344 (U.G.E.). To our knowledge, no double blind studies have been performed to compare their value. In this study @entity4390 (2 mg i.v.) was compared with @entity3175 (t mg i.v.) in 200 consecutive @entity1 undergoing elective U.G.E. The study was randomized and double blind in regard to both endoscopists and @entity1 . All @entity1 were given @entity3897 (0.4 mg i.v.) and a throat spray with 2% @entity6513 . @entity1 who needed supplemental medication were given @entity3175 and excluded from final analysis. A graded questionnaire was recorded by endoscopists and @entity1 after U.G.E., and a further anonymous questionnaire was returned by @entity1 four days later. Statistical analysis revealed that @entity4390 was superior at facilitating intubation and providing more relaxation as judged by the endoscopist. @entity1 questionnaires, four days after U.G.E., indicated less distress during intubation and examination with @entity4390 . @entity390 , @entity391 , @entity2730 and @entity3527 were uncommon after either @entity4390 or @entity3175 .
